Lidocaine Hydrochloride Injection, Solution
Product Images NDC 71872-7362

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 71872-7362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7362.pdp (7362)

7362.pdp (7362)
This text provides detailed information on a 1% Lidocaine HCI Injection, USP in a 500 mg/50 ml multiple-dose vial. It includes the expiration date, composition, storage instructions, and information on resterilization. The text also mentions that the container closure does not contain natural rubber latex. It is recommended to consult the package insert for dosage and full prescribing information. The product is to be sold only as an unbroken package and is distributed by Medical Purchasing Solutions.*
FDA Label Image

7362m.pdp (7362m)

7362m.pdp (7362m)
The text contains information about a product labeled as "Avenacy". It mentions manufacturing details, a contact address in Schaumburg, USA, and that it is made in India. It provides instructions on the usage of the product, stating it is for filtration and nerve block and not for caudal or epidural use. The product comes in a 50 mL multiple-dose vial.*
FDA Label Image

Structural Formula (Lid0w 0000 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.